This blog is related to the various litigations related to patents w.r.t pharma industry.
Wednesday, August 26, 2009
Endo Pharmaceuticals to Partner With ProStrakan to Commercialize Fortesta in the U.S.
Endo Pharmaceuticals today announced that it has signed an agreement with U.K.-based ProStrakan Group plc for the exclusive right to commercialize FORTESTA(TM) (testosterone gel) 2 percent in the United States.
No comments:
Post a Comment